Search Result "p53AIP1"
Arsenic Trioxide in Hematological Malignancies: The New Discovery of an Ancient Drug
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 6 Year: 2006 Page: 397-405
Author(s): A. Bonati, V. Rizzoli, P. Lunghi
Chemoresistance of Cancer Cells: Oncogenic Mutation of the p53 Tumor Suppressor Gene
Journal: Current Signal Transduction Therapy
Volume: 11 Issue: 1 Year: 2016 Page: 3-8
Author(s): Daisuke Uchida,Hitoshi Kawamata,Fujiyuki Inaba,Ichio Fukasawa,Takahiro Fujimori
Targeting p73 - a Potential Approach in Cancer Treatment
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 6 Year: 2011 Page: 591-602
Author(s): Neda Slade, Andela Horvat
Traditional Chinese Medicine Remedy to Jury: The Pharmacological Basis for the Use of Shikonin as an Anticancer Therapy
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 23 Year: 2013 Page: 2892-2898
Author(s): I. Andujar,M. C. Recio,R. M. Giner,J. L. RÃos
Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 256-271
Author(s): Jozefa Wasierska-Gadek, Margarita Maurer
Radiation Oncology and Molecular-Targeted Therapy for EGFR and its Signal Transduction Pathways: Molecular Basis and Clinical Application for Improvement of Radiotherapeutic Outcomes
Journal: Current Signal Transduction Therapy
Volume: 5 Issue: 3 Year: 2010 Page: 197-205
Author(s): Tetsuo Akimoto, Norio Mitsuhashi
Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer
Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 12 Year: 2014 Page: 1141-1157
Author(s): Rashmi Mittal,Narender Chaudhry,Shubha Pathania,Tapan K. Mukherjee
Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2036-2055
Author(s): Gaetano Serviddio, Antonino Davide Romano, Tommaso Cassano, Francesco Bellanti, Emanuele Altomare, Gianluigi Vendemiale
Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 8 Year: 2008 Page: 741-752
Author(s): Ankur Kumar Upadhyay, Amrendra Kumar Ajay, Sandeep Singh, Manoj Kumar Bhat
Chemotherapeutic Agents That Induce Mitochondrial Apoptosis
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 7 Year: 2004 Page: 577-590
Author(s): Tadashi Asakura, Kiyoshi Ohkawa